Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU ยท Real-Time Price ยท USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST
Aytu BioPharma Revenue
Aytu BioPharma had revenue of $14.84M in the quarter ending September 30, 2026, with 6.87% growth. This brings the company's total for the last twelve months to $58.52M, down -8.12% year-over-year. In the fiscal year ending June 30, 2026, Aytu BioPharma had annual revenue of $57.57M, down -13.27%. That makes Aytu BioPharma the 26,850th largest company in the world by revenue and 3,661st in the United States.
Revenue (ttm)
$58.52M
Revenue Growth
-8.12%
P/S Ratio
0.49
Revenue / Employee
$770,053
Employees
76
Market Cap
28.91M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 57.57M | -8.81M | -13.27% |
| Jun 30, 2025 | 66.38M | 1.20M | 1.84% |
| Jun 30, 2024 | 65.18M | -42.22M | -39.31% |
| Jun 30, 2023 | 107.40M | 10.73M | 11.10% |
| Jun 30, 2022 | 96.67M | 31.04M | 47.29% |
| Jun 30, 2021 | 65.63M | 38.00M | 137.52% |
| Jun 30, 2020 | 27.63M | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | 3.66M | -2.78M | -43.19% |
| Jun 30, 2017 | 6.44M | - | - |
| Jun 30, 2016 | - | - | - |
| Jun 30, 2015 | 261.78K | 260.78K | 26,078.20% |
| Aug 31, 2014 | 1.00K | -57.93K | -98.30% |
| Jun 30, 2014 | 58.93K | 57.18K | 3,267.37% |
| Aug 31, 2013 | 1.75K | -48.25K | -96.50% |
| Jun 30, 2013 | 50.00K | 48.25K | 2,757.14% |
| Aug 31, 2012 | 1.75K | - | - |
| Aug 31, 2011 | - | - | - |
| Aug 31, 2010 | - | - | - |
| Aug 31, 2009 | 1.75K | - | - |
| Aug 31, 2008 | - | - | - |
| Aug 31, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 72.58M |
| SCYNEXIS | 18.88M |
| Zhengye Biotechnology Holding | 15.45M |
| China Pharma Holdings | 4.31M |
| TherapeuticsMD | 3.75M |
| Akanda | 662.47K |
| Incannex Healthcare | 12.00K |
AYTU News
- 4 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Aytu BioPharma, Inc. (Nasdaq โ AYTU), Rapid Micro Biosystems, Inc. (Nasdaq โ RPID), Advantage Energy Ltd. (OTC โ AAVVF), Canaccord Genuity Group Inc. (OTC โ CCORF) - GlobeNewsWire
- 4 days ago - Aytu BioPharma downgraded to Hold from Buy at Maxim - TheFly
- 5 days ago - Aytu BioPharma downgraded to Hold from Buy at Lake Street - TheFly
- 5 days ago - Aytu BioPharma reports Q1 EPS (20c), consensus (18c) - TheFly
- 5 days ago - AYTU BioPharma trading resumes - TheFly
- 5 days ago - Aytu BioPharma to be acquired by Rosemont Pharmaceuticals for $2.70 per share - TheFly
- 5 days ago - Aytu BioPharma Earnings release: Q1 2027 - Filings
- 5 days ago - Aytu BioPharma Quarterly report: Q1 2027 - Filings